InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（37 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
37
T+90 胜率
100%
T+90 平均收益
+16.1%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the detailed record of transactions filed by Shanmugam Muthusamy, 首席运营官. Director active across 1 company, notably ANI Pharmaceuticals INC. Aggregated, 47 filings have been published. Split: 1 buy · 37 sells. Total volume traded: €31.2m. Activity tracked since 17 March 2022. The latest transaction was disclosed on 26 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Shanmugam Muthusamy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报47 总计
11,116 股@ US$77.152.3% 占其流量Common StockSEC:0001870913-26-000005:0
2,898 股@ US$76.250.6% 占其流量Common StockSEC:0001870913-26-000002:0
47,012 股@ US$90.2711.7% 占其流量Common StockSEC:0001870913-25-000008:0
47,010 股@ US$89.4813.1% 占其流量Common StockSEC:0001870913-25-000006:0
700 股@ US$76.830.2% 占其流量Common StockSEC:0001870913-25-000004:0
14,362 股0Common StockSEC:0001870913-25-000002:0
9,574 股0Common StockSEC:0001870913-25-000002:1
2,743 股@ US$62.000.7% 占其流量Common StockSEC:0001870913-24-000028:0
11,000 股@ US$63.382.7% 占其流量Common StockSEC:0001870913-24-000026:0
20,000 股@ US$58.904.6% 占其流量Common StockSEC:0001870913-24-000024:0
7,946 股@ US$61.411.9% 占其流量Common StockSEC:0001870913-24-000022:0
12,855 股@ US$61.813.0% 占其流量Common StockSEC:0001870913-24-000020:0
14,850 股@ US$65.863.7% 占其流量Common StockSEC:0001870913-24-000018:0
10,423 股@ US$64.982.7% 占其流量Common StockSEC:0001870913-24-000016:0
7,414 股@ US$66.331.9% 占其流量Common StockSEC:0001870913-24-000014:0
10,000 股@ US$67.172.6% 占其流量Common StockSEC:0001870913-24-000012:0
10,093 股@ US$65.352.5% 占其流量Common StockSEC:0001870913-24-000010:0
1,122 股@ US$67.670.3% 占其流量Common StockSEC:0001870913-24-000008:0
13,421 股0Common StockSEC:0001870913-24-000006:0
4,524 股@ US$55.571.0% 占其流量Common StockSEC:0001870913-24-000004:0
5,692 股@ US$55.951.2% 占其流量Common StockSEC:0001870913-24-000004:1
15,000 股@ US$56.443.2% 占其流量Common StockSEC:0001870913-24-000004:2
5,000 股@ US$55.631.1% 占其流量Common StockSEC:0001870913-24-000002:0
11,974 股@ US$52.442.4% 占其流量Common StockSEC:0001870913-23-000020:0
13,026 股@ US$52.442.6% 占其流量Common StockSEC:0001870913-23-000020:1
47 条申报中的 25 条
About Shanmugam Muthusamy
Shanmugam Muthusamy is Head of R&D, COO-NOVITIUM OPS at ANI Pharmaceuticals INC (XNAS). He has 47 filings in total, and across the 47 sampled filings the reported transactions run from 2021-11-23 to 2026-03-02, with EUR 125433 of buys and EUR 31054374 of sells; the modal transaction nature is sell.
